Faouzi Saliba

Summary

Country: France

Publications

  1. doi Renal impairment and amphotericin B formulations in patients with invasive fungal infections
    Faouzi Saliba
    Assistance Publique Hopitaux de Paris AP HP, Hopital Paul Brousse, Centre Hepato Biliaire, Universite Paris Sud, Villejuif, France
    Med Mycol 46:97-112. 2008
  2. doi Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era
    Faouzi Saliba
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Clin Transplant 27:E454-61. 2013
  3. doi Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study
    F Saliba
    Hepatobiliary Center, AP HP Hopital Paul Brousse, Universite Paris Sud, Villejuif, France
    Am J Transplant 13:1734-45. 2013
  4. doi Cirrhotic patients in the ICU: prognostic markers and outcome
    Faouzi Saliba
    Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Curr Opin Crit Care 19:154-60. 2013
  5. doi Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients
    Faouzi Saliba
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Med Mycol 51:155-63. 2013
  6. doi Emerging fungal infections
    Faouzi Saliba
    Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Expert Rev Anti Infect Ther 10:419-21. 2012
  7. doi Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns
    Faouzi Saliba
    Hepatobiliary Center, Paul Brousse Hospital, Villejuif, France
    Ther Apher Dial 14:116-23. 2010
  8. pmc The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure
    Faouzi Saliba
    AP HP, Hopital Paul Brousse, Service d Hepato Gastroenterologie, Villejuif, 94804, France
    Crit Care 10:118. 2006
  9. doi Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis
    Faouzi Saliba
    Centre Hepato Biliaire, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, Universite Paris Sud, Villejuif, France
    Liver Transpl 17:905-13. 2011
  10. ncbi Antifungals and renal safety--getting the balance right
    Faouzi Saliba
    Department of Liver Disease and Liver Transplantation, Assistance Publique Hopitaux de Paris, Hopital Paul Brousse, Villejuif, France
    Int J Antimicrob Agents 27:21-4. 2006

Collaborators

Detail Information

Publications46

  1. doi Renal impairment and amphotericin B formulations in patients with invasive fungal infections
    Faouzi Saliba
    Assistance Publique Hopitaux de Paris AP HP, Hopital Paul Brousse, Centre Hepato Biliaire, Universite Paris Sud, Villejuif, France
    Med Mycol 46:97-112. 2008
    ..Based on our review we conclude that lipid formulations of amphotericin B are an important strategy to preserve renal function and improve survival in critically ill patients who require treatment for systemic fungal infections...
  2. doi Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era
    Faouzi Saliba
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Clin Transplant 27:E454-61. 2013
    ..1-fold or 3.1-fold increase in relative risk of invasive fungal infection. In conclusion, liver transplant patients with a MELD score ≥ 20, and particularly patients with a score ≥ 30, are candidates for antifungal prophylaxis...
  3. doi Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study
    F Saliba
    Hepatobiliary Center, AP HP Hopital Paul Brousse, Universite Paris Sud, Villejuif, France
    Am J Transplant 13:1734-45. 2013
    ..2% of TAC Control patients. Early introduction of everolimus with reduced-exposure tacrolimus at 1 month after liver transplantation provided a significant and clinically relevant benefit for renal function at 2 years posttransplant...
  4. doi Cirrhotic patients in the ICU: prognostic markers and outcome
    Faouzi Saliba
    Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Curr Opin Crit Care 19:154-60. 2013
    ..Highlight the correlation between the development of sepsis and/or organ failure and outcome...
  5. doi Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients
    Faouzi Saliba
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Med Mycol 51:155-63. 2013
    ....
  6. doi Emerging fungal infections
    Faouzi Saliba
    Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Expert Rev Anti Infect Ther 10:419-21. 2012
    ..A quick focus on some relevant clinical presentations is presented here...
  7. doi Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns
    Faouzi Saliba
    Hepatobiliary Center, Paul Brousse Hospital, Villejuif, France
    Ther Apher Dial 14:116-23. 2010
    ..Two patients are alive at 1.5 and 3 years follow-up with a normally functioning graft. The third patient died with a functioning graft, one month after the transplantation, from septic complications...
  8. pmc The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure
    Faouzi Saliba
    AP HP, Hopital Paul Brousse, Service d Hepato Gastroenterologie, Villejuif, 94804, France
    Crit Care 10:118. 2006
    ..It is a major improvement in the management of patients with hepatic failure that could permit, when appropriately indicated, recovery from an acute episode and enhance the chances of survival while waiting for an available organ donor...
  9. doi Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis
    Faouzi Saliba
    Centre Hepato Biliaire, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, Universite Paris Sud, Villejuif, France
    Liver Transpl 17:905-13. 2011
    ..Randomized trials in which maintenance liver transplant patients are switched to everolimus in response to clinical indications or preemptively are warranted...
  10. ncbi Antifungals and renal safety--getting the balance right
    Faouzi Saliba
    Department of Liver Disease and Liver Transplantation, Assistance Publique Hopitaux de Paris, Hopital Paul Brousse, Villejuif, France
    Int J Antimicrob Agents 27:21-4. 2006
    ..This paper examines the pharmacological alternatives that could provide a more suitable balance between clinical efficacy and renal safety...
  11. ncbi Pulmonary complications after elective liver transplantation-incidence, risk factors, and outcome
    Eric Levesque
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Transplantation 94:532-8. 2012
    ..The links between this dysfunction and PPC have not been clearly established. In this present cohort study, we evaluated the incidence and profile of post-LT pneumonia and identified potential preoperative risk factors...
  12. doi Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adults
    Mylene Sebagh
    1 Laboratoire d Anatomie Pathologique, AP HP Hopital Paul Brousse, Villejuif, France 2 Division of Transplantation, University of Pittsburgh Medical Center, Pittsburgh, PA 3 Centre Hépato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France 4 Unité Mixte de Recherche 785, Inserm Univ Paris Sud, Villejuif, France 5 Laboratoire d Immunologie Clinique, AP HP Hôpital Saint Antoine, Paris, France 6 Laboratoire de Virologie, AP HP Hopital Paul Brousse, Villejuif, France 7 Address correspondence to Mylène Sebagh, M D, Laboratoire d Anatomie Pathologique, AP HP Hopital Paul Brousse, 14, avenue Paul Vaillant Couturier, 94 804 Villejuif Cedex, France
    Transplantation 96:670-8. 2013
    ..This study aimed to determine which histologic features correlated best with clinical and serologic features of dAIH...
  13. doi Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients
    Mylene Sebagh
    Laboratoire d Anatomie Pathologique, AP HP Hopital Paul Brousse, Villejuif, France
    J Hepatol 56:840-7. 2012
    ..Most liver transplant centres have discontinued the practice of protocol liver biopsies (LB), mainly because of the perceived lack of therapeutic benefit. This study aimed to examine the usefulness of 20-year LBs...
  14. ncbi Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis
    Philippe Ichai
    Centre Hépatobiliaire and INSERM Unit 785, Assistance Publique Hopitaux de Paris, Universite Paris Sud, Hopital Paul Brousse, Villejuif, France
    Liver Transpl 13:996-1003. 2007
    ..Among the untreated patients, 3 survived after LT and 1 died without LT. In conclusion, corticosteroid therapy is of little benefit in severe and fulminant forms of AIH; it may favor septic complications and should not delay LT...
  15. doi Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis
    Bruno Roche
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Liver Transpl 14:1766-77. 2008
    ..Fibrosis stage remained stable in patients with SVR and increased in nonresponders. Fibrosis stage > or =3 was associated with a high rate of liver failure, arguing for an early introduction of antiviral therapy...
  16. doi Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation
    Mylene Sebagh
    Laboratoire d Anatomie Pathologique, Assistance Publique Hopitaux de Paris, Villejuif, France
    Liver Transpl 17:798-808. 2011
    ..The histological resolution of iVOD/SOS after increase in immunosuppression suggests an immune-mediated origin. Better optimization of immunosuppression may be a curative treatment...
  17. doi Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation
    Eric Levesque
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Liver Transpl 15:1358-64. 2009
    ..8 to 10.3 +/- 2.5%/minute; P < 0.002). In conclusion, after LT, PDR-ICG (a noninvasive technique), measured regularly during the first 5 postoperative days, is a safe technique that can predict early postoperative complications...
  18. doi Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit
    Eric Levesque
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    J Hepatol 56:95-102. 2012
    ..Identifying patients in whom ICU care will be useful can be challenging. The aim of this study was to assess the predictive value of prognostic scores with respect to mortality and to identify mortality risk factors...
  19. doi Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation
    Philippe Ichai
    Centre Hépato BiliaireAP HP Hôpital Paul Brousse, Villejuif, France
    Liver Transpl 16:1136-46. 2010
    ..In conclusion, hepatitis secondary to ATT can be successfully treated with alternative anti-TB regimens. The use of RIF in LT patients may lead to acute rejection. RIF should therefore be avoided in these patients...
  20. ncbi Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis
    Philippe Ichai
    Centre Hepatobiliaire, Assistance Publique Hopitaux de Paris, Universite Paris Sud, Hopital Paul Brousse, 12 avenue Paul Vaillant Couturier, 94800 Villejuif Cedex, France
    Liver Transpl 11:1550-5. 2005
    ..Diagnosis methods providing fast results (real-time polymerase chain reaction [PCR]) should be implemented...
  21. pmc Decision for retransplantation of the liver: an experience- and cost-based analysis
    Daniel Azoulay
    Hepatobiliary Center, Hospital Paul Brousse, Assitance Publique Hôpitaux de Paris and Université Paris Sud, Villejuif, France
    Ann Surg 236:713-21; discussion 721. 2002
    ..To determine the patient factors affecting patient outcome of first liver retransplantation at a single center to help in the decision process for retransplantation...
  22. doi Caval inflow to the graft for liver transplantation in patients with diffuse portal vein thrombosis: a 12-year experience
    Prashant Bhangui
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif Cedex, France
    Ann Surg 254:1008-16. 2011
    ..To analyze the short- and long-term results of cavoportal anastomosis (CPA) and renoportal anastomosis (RPA) in 20 consecutive liver transplantation (LT) candidates with diffuse portal vein thrombosis (PVT)...
  23. ncbi Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study
    Faouzi Saliba
    Assistance Publique Hopitaux de Paris, Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Liver Transpl 13:136-44. 2007
    ..Tac induced a significantly higher incidence of NODM in the HCV(+) compared to the HCV(-) patients. The treatment should therefore be tailored to the patient's risk especially in case of HCV infection...
  24. doi Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection
    Robbert J de Haas
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Ann Surg 253:1069-79. 2011
    ..An expansion of resectability criteria of colorectal liver metastases (CLM) is justified provided "acceptable" short-term and long-term outcomes. The aim of the present study was to ascertain this paradigm in an era of modern liver surgery...
  25. ncbi Pneumocystis pneumonia: an opportunistic infection occurring in patients with severe alcoholic hepatitis
    Luciana Costa Faria
    AP HP Hopital Paul Brousse, Hepatobiliary Center, Villejuif, France
    Eur J Gastroenterol Hepatol 20:26-8. 2008
    ..Long-term corticotherapy represents a risk for Pneumocystis pneumonia...
  26. ncbi Donor age influences 10-year liver graft histology independently of hepatitis C virus infection
    Kinan Rifai
    Centre Hepato Biliaire, Hopital Paul Brousse, Villejuif Assistance Publique Hôpitaux de Paris, Universite Paris Sud, 12 14 avenue Paul Vaillant Couturier, 94800 Villejuif, France
    J Hepatol 41:446-53. 2004
    ..Factors influencing the long-term histological outcome of liver graft are not known. We conducted a prospective study based on a 10-year liver biopsy in order to identify the main factors influencing long-term graft histology...
  27. pmc In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection
    Daniel Azoulay
    Centre Hepato Biliaire, Département de Chirurgie Hépato Biliaire, IFR 89 9, Hopital Paul Brousse, Villejuif, France
    Ann Surg 241:277-85. 2005
    ..The safe duration of TVE is still debated. Promising results have been reported following TVE associated with hypothermic perfusion of the liver with durations of up to several hours. The 2 techniques have not been compared so far...
  28. doi Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients
    Laurence Bonhomme-Faivre
    Pharmacy Pharmacology Service, Hopital Paul Brousse, Villejuif, France
    Am J Health Syst Pharm 66:1645-51. 2009
    ..To determine whether the ABCB1 single-nucleotide polymorphism (SNP) 3435C>T was associated with variation in the tacrolimus concentration:dose ratio (C:D) in 42 liver transplant recipients during three months after transplantation...
  29. ncbi Fulminant hepatitis after grand mal seizures: mechanisms and role of liver transplantation
    Philippe Ichai
    Centre Hepatobiliaire, Assistance Publique Hopitaux de Paris, Universite Paris Sud, Hopital Paul Brousse, Villejuif, France
    Hepatology 38:443-51. 2003
    ..The neurological prognosis and overall survival of these patients remains poor...
  30. ncbi Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients
    Jean Charles Duclos-Vallée
    Centre Hépato Biliaire Hôpital Paul Brousse, Assistance Publique Hopitaux de Paris, 94804 Villejuif, France
    J Hepatol 42:341-9. 2005
    ..We report the Paul Brousse Hospital experience of transplantation for end stage cirrhosis in HIV-HCV co-infected patients...
  31. doi Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation
    Prashant Bhangui
    Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, Villejuif, France
    Hepatology 53:1570-9. 2011
    ..On an intention-to-treat basis, the overall survival (OS) in the two groups was comparable. Patients beyond the Milan and UCSF criteria showed a trend toward worse outcomes with LDLT compared with DDLT (P = 0.06)...
  32. ncbi The positive financial impact of using an Intensive Care Information System in a tertiary Intensive Care Unit
    Eric Levesque
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Int J Med Inform 82:177-84. 2013
    ..The aim of this study was to evaluate the effects of using an Intensive Care Information System (ICIS) on the incidence of coding errors and its impact on the ICU budget allocated...
  33. ncbi [Increased long-term permeability of transjugular intrahepatic portosystemic shunt (TIPS) in 218 cirrhotic patients, with strict monitoring]
    Denis Castaing
    Centre Hepato Biliaire, Hopital Paul Brousse, AP HP, Universite Paris Sud, Paris, Villejuif 94
    Presse Med 33:1239-46. 2004
    ..To measure the impact of strict monitoring on long term permeability of TIPS...
  34. doi Respiratory impact of paracentesis in cirrhotic patients with acute lung injury
    Eric Levesque
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    J Crit Care 26:257-61. 2011
    ..Ascites may contribute to the loss of lung volume and alter the gas exchange in cirrhotic patients with acute lung injury (ALI)...
  35. ncbi Medical community preferences concerning adult living related donor liver transplantation
    Denis Castaing
    Centre Hepato Biliaire, Hopital Paul Brousse, UPRES 1596, Universite Paris Sud, Villejuif
    Gastroenterol Clin Biol 30:183-7. 2006
    ..To assess acceptance and acceptable estimated mortality levels for right lobe adult-to-adult living related liver transplantation for the medical and allied professions...
  36. ncbi MDR-1 C3435T polymorphism influences cyclosporine a dose requirement in liver-transplant recipients
    Laurence Bonhomme-Faivre
    Service Pharmacie Pharmacologie, Hopital Paul Brousse, Villejuif, France
    Transplantation 78:21-5. 2004
    ..CsA is a substrate for P-glycoprotein, a member of the ABC transporter family encoded by the multiple drug-resistant gene MDR1...
  37. ncbi [Pneumocystis carinii and cytomegalovirus pneumonia after corticosteroid therapy in acute severe alcoholic hepatitis: 2 case reports]
    Philippe Ichai
    Centre Hepato Biliaire, Hopital Paul Brousse, UPRES 1596, Universite Paris Sud, Villejuif, France
    Gastroenterol Clin Biol 26:532-4. 2002
    ..In conclusion, Pneumocystis carinii pneumonia is a potential complication of steroid treatments for acute alcoholic hepatitis and should be suspected in case of unexplained pulmonary infection...
  38. ncbi First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital
    Najiby Kassis-Chikhani
    Service de Microbiologie, Hopital Paul Brousse, France
    J Antimicrob Chemother 57:142-5. 2006
    ..We studied eight imipenem-resistant isolates of Klebsiella pneumoniae involved in an outbreak in a French teaching hospital...
  39. doi Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
    Richard Moreau
    Service d Hepatologie, Hopital Beaujon, Assistance Publique Hopitaux de Paris, Clichy, France
    Gastroenterology 144:1426-37, 1437.e1-9. 2013
    ..We aimed to identify diagnostic criteria of ACLF and describe the development of this syndrome in European patients with AD...
  40. doi [Fulminant and subfulminant hepatitis: causes and treatment]
    Philippe Ichai
    Centre Hepatobiliaire, Réanimation hépatique, AP HP Hopital Paul Brousse, Universite Paris Sud, UMR S 785, INSERM Unité 785, Villejuif, France
    Presse Med 38:1290-8. 2009
    ..all from the onset of the disease...
  41. doi Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study
    Svetlana Karie-Guigues
    Service de Nephrologie, Groupe Hospitalier de la Pitié Salpêtrière, Paris, France
    Liver Transpl 15:1083-91. 2009
    ..It seems likely that early intervention for CNI reduction is best for reducing the use of CNIs in the long term...
  42. doi Outcome of patients with cirrhosis requiring mechanical ventilation in ICU
    Eric Levesque
    AP HP Hopital Henri Mondor, Anesthésie et Réanimations Chirurgicales, Creteil, France AP HP Hôpital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    J Hepatol 60:570-8. 2014
    ..The aim of our study is to assess the prognosis of these patients, their 1-year outcome and to analyze predictive factors of long-term mortality...
  43. ncbi Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation
    Didier Samuel
    Centre Hepatobiliaire, UPRES 1596, Equipe INSERM 99 41, Assistance Publique Hopitaux de Paris, Universite Paris Sud, Hopital Paul Brousse, Villejuif, France
    Transplantation 73:257-64. 2002
    ..We assessed the HepatAssist 2000, a liver-assist system containing porcine hepatocytes, as a bridge to transplantation in patients with acute liver failure...
  44. ncbi Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation
    Caroline Creput
    Nephrology and Transplantation Unit, Kremlin Bicetre Hospital, Kremlin Bicêtre France
    Liver Transpl 13:1004-10. 2007
    ..In liver recipients with CRF, a reduction or withdrawal of CNI concomitantly with the introduction of MMF was safe and was associated with an improvement in renal function...
  45. ncbi Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients
    Frederik Nevens
    Department of Hepatology, University Hospital Gasthuisberg K U Leuven, Leuven, Belgium
    Liver Transpl 12:1489-95. 2006
    ..Liver transplant candidates could benefit from the use of this experimental adjuvanted HB vaccine to further increase their protection against HB infection...
  46. ncbi Liver transplantation for fulminant hepatic failure due to cocaine intoxication in an alcoholic hepatitis C virus-infected patient
    Monika Hurtova
    Transplantation 73:157-8. 2002